PPT-Diagnosis, Prevention and Management of Statin Adverse Effe

Canadian Consensus Working Group Update 2016 GB John Mancini MD Steven Baker MD Jean Bergeron MD David Fitchett MD Jiri Frohlich MD Jacques Genest MD Milan Gupta MD Robert A Hegele MD . Nice Guidelines . Who to offer therapy to?. Offer . lipid-modification . therapy. to. people aged 84 years and younger if their estimated 10-year risk of developing cardiovascular disease (CVD) using the . Morten . Rix . Hansen. Anton Pottegård . Asbjørn . Hróbjartsson. Per Damkier . René dePont Christensen . Kasper Søltoft Larsen . Jesper Hallas. 1. Clinical Pharmacology. Department of Public Health. Teaching Aims. You will learn all about adverse donor reaction and prevention of certain reactions. . You will learn to define, identify/diagnose and handle all the reactions.. Adverse Donor Reactions. Annapoorna Kini, MD, MRCP, FACC. Director, Cardiac Catheterization Lab. Director, Structural Heart Intervention Program. Director, Interventional Cardiology Fellowship Program . Zena and Michael A. Wiener Professor of Medicine. . U. nderstanding . S. tatin Use in . A. merica and . G. aps in . E. ducation. The Largest Known Cholesterol Survey . Conducted in the U.S. . USAGE Survey Rationale—I . Lack of adherence & persistence of statin therapy is a common problem. Under-Representation of Women . in Clinical Trials. CVD in Women. Women. ’. s CV Risk is Often Misunderstood or Misdiagnosed. Gender Disparities in Screening, Diagnosis, and Treatment of Dyslipidemia. James J. Lehman, DC, MBA, FACO. Associate Professor of Clinical Sciences. School of Chiropractic. Director. Community Health Clinical Education. University of Bridgeport. Learning Objectives. . Organize a clinical thought process while performing a neuromusculoskeletal evaluation of a patient with statin myopathy and piriformis syndrome.. Diagnosis, Prevention and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016) G.B. John Mancini, MD, Steven Baker, MD, Jean Bergeron, MD, David Fitchett, MD, Cardiometabolic Disease Is an Epidemic. Clinical Diagnosis of Metabolic Syndrome. Adiposity, Insulin Resistance, Inflammation and Oxidative Stress - What's the Correlation?. Typical Characteristics of the Patient With MetSyn. Outline the issue of medication nonadherence and reasons that patients may not adhere to medications (with a particular focus on statin). Review strategies to improve patient adherence to statins. 2. Debra Griner, MS FNP-C. Mesa Primary Care. Casper, Wyoming. Disclosures. None. Objectives. Identify causes of hyperlipidemia (HLD). Treatment Guidelines. Who should be treated for HLD & Goal. 3. Prevention. Simplied lipid guidelinesPrevention and management of cardiovascular disease in primary care EDITOR’S KEY POINTS Clinical practice guidelines are often developed with little input from the Slide deck. The full text of the paper is available at. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31652-0/fulltext. . Rationale. Lipoprotein. (a) . is. an . established. . risk. Dr Deep Shah, . Clinical. . Lead UCL Partners. Dominic . Studart. , North Thames GMSA Familial . Hypercholesterolaemia. Project Nurse . Aims. What is FH? . Diagnosing FH. Implementing UCLPartners FH Searches .